ALK5/VEGFR2 dual inhibitor TU2218 alone or in combination with immune checkpoint inhibitors enhances immune-mediated antitumor effects
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
ALK5/VEGFR2 dual inhibitor TU2218 alone or in combination with immune checkpoint inhibitors enhances immune-mediated antitumor effects ; volume:73 ; number:10 ; day:6 ; month:8 ; year:2024 ; pages:1-20 ; date:10.2024
Cancer immunology immunotherapy ; 73, Heft 10 (6.8.2024), 1-20, 10.2024
- Creator
-
Kim, Nam-Hoon
Lee, Jihyun
Kim, Seung-Hyun
Kang, Seong-Ho
Bae, Sowon
Yu, Chan-Hee
Seo, Jeongmin
Kim, Hun-Taek
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-024-03777-4
- URN
-
urn:nbn:de:101:1-2411292059361.135080363964
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Nam-Hoon
- Lee, Jihyun
- Kim, Seung-Hyun
- Kang, Seong-Ho
- Bae, Sowon
- Yu, Chan-Hee
- Seo, Jeongmin
- Kim, Hun-Taek
- SpringerLink (Online service)
Other Objects (12)
A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death
Immune checkpoint inhibitors and risk of immune-mediated adverse events: a cohort study comparing extended versus standard interval administration
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis
Immune monitoring and treatment in immune-mediated inflammatory diseases
Adaptive immune responses, immune escape and immune-mediated pathogenesis during HDV infection
Immune-mediated neurological complications and dengue
Cancer immunotherapy beyond immune checkpoint inhibitors
Immune checkpoint inhibitor-related acral vasculitis
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Safety of sequential immune checkpoint inhibitors after prior immune therapy
Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death
Immune checkpoint inhibitors and risk of immune-mediated adverse events: a cohort study comparing extended versus standard interval administration
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis
Immune monitoring and treatment in immune-mediated inflammatory diseases
Adaptive immune responses, immune escape and immune-mediated pathogenesis during HDV infection
Immune-mediated neurological complications and dengue
Cancer immunotherapy beyond immune checkpoint inhibitors
Immune checkpoint inhibitor-related acral vasculitis
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Safety of sequential immune checkpoint inhibitors after prior immune therapy
Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death
Immune checkpoint inhibitors and risk of immune-mediated adverse events: a cohort study comparing extended versus standard interval administration
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis
Immune monitoring and treatment in immune-mediated inflammatory diseases
Adaptive immune responses, immune escape and immune-mediated pathogenesis during HDV infection
Immune-mediated neurological complications and dengue
Cancer immunotherapy beyond immune checkpoint inhibitors
Immune checkpoint inhibitor-related acral vasculitis
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Safety of sequential immune checkpoint inhibitors after prior immune therapy